Mindset Pharma Identifies New Pharmacological Insights of First Generation Psychedelics Through its COPE Program with InterVivo Solutions
Ryan Allway February 17th, 2022 Psychedelics TORONTO, Feb. 17, 2022 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”), a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet medical needs,... Read more
Neuroplasticity, Psychedelics, and Mental Health
Robin Lefferts February 17th, 2022 Psychedelics, Top News The brain is a tangled, incredibly complex mass of about 86 billion neurons. The ability to create new neurons, called neurogenesis, was long thought to stop by the age of 25. There is some debate, however, as one recent study put... Read more
NeonMind to Open its Inaugural Specialty Mental Health Clinic in Mississauga, Ontario
Ryan Allway February 17th, 2022 News, Top News Mississauga facility expected to begin treatment services in the Second Half of 2022  First location selected as part of a nationwide buildout of NeonMind-branded clinics offering interventional psychiatry treatments Vancouver, B.C. – February 17, 2022: NeonMind Biosciences Inc. (CSE: NEON) (OTCQB: NMDBF) (FRA: 6UF)... Read more
TILT Enters into Multi-State Agreement to Manufacture and Distribute Cannabis Brand Toast™
Ryan Allway February 17th, 2022 News, Top News PHOENIX, February 17, 2022 (Globe Newswire) — Tilt Holdings Inc. (“Tilt” or “Company”) (NEO: dance) (OTCQX: TLLTF), a global provider of cannabis business solutions that include inhalation technology, cultivation, manufacturing, processing, brand development and retail, today announced a multi-state licensing agreement. Toast™An Aspen, Colorado-born national cannabis... Read more
This addition collectively brings the Company’s total clinic count to 16 globally, which includes presence in Colombia, Peru and the United Kingdom Peru represented 5% of the total Latin America unit sales in 2021 In the second half of 2021, the Company opened its first Zerenia™ clinic in Lima, in partnership with Clínica Montesur. Since opening the... Read more
Field Trip Health Ltd. Reports Third Fiscal Quarter 2022 Financial Results and Provides Business Update

During the quarter, Field Trip progressed its strategy of building the leading psychedelic therapy company through its Field Trip Health division and continued to invest in its lead drug development program.

Read more
Novamind Advances Clinical Pilot for Frontline KAP

Novamind announces a “clinical pilot” aimed at bringing ketamine-assisted therapy to treat the mental health disorders of frontline healthcare workers.

Read more
Turning the Spotlight on Celebrity Endorsement of Cannabis Companies
by Matthew Kittay, William Bogot, Joshua Horn, and Michael Reinert, Attorneys at Fox Rothschild LLP As cannabis brands expand nationally in the United States, and the industry begins to consolidate, it is not a surprise that enterprises are looking to distinguish their products on the shelves and in the mind of the... Read more
BOYNE CAPITAL PARTNERS and A&A GLOBAL IMPORTS have acquired APHECAL ENTERPRISES, INC.
PRESS RELEASE BOYNE CAPITAL PARTNERS and A&A GLOBAL IMPORTS have acquired APHECAL ENTERPRISES, INC. Miami, FL – () Boyne Capital Partners (“Boyne”) is pleased to announce that its portfolio company A&A Global Imports, LLC dba www.marijuanapackaging.com or “MJ Pack” (“A&A”) acquired Aphecal Enterprises, Inc. dba www.420packaging.com (“Aphecal”... Read more
Security Solutions for Cannabis Businesses: Avoid these common mistakes when selecting your access control solution: Part 2 of 3
This is part two of a three-part series on how to plan, build, and assemble security solutions for cannabis businesses. In part one of this series, we looked at some of the key considerations that should inform your selection of a video management system. In the final article in... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )